These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16904335)

  • 1. C-type natriuretic peptide and heart failure.
    Del Ry S; Passino C; Emdin M; Giannessi D
    Pharmacol Res; 2006 Nov; 54(5):326-33. PubMed ID: 16904335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial production of C-type natriuretic peptide in chronic heart failure.
    Kalra PR; Clague JR; Bolger AP; Anker SD; Poole-Wilson PA; Struthers AD; Coats AJ
    Circulation; 2003 Feb; 107(4):571-3. PubMed ID: 12566368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-type natriuretic peptide: a new cardiac mediator.
    Del Ry S
    Peptides; 2013 Feb; 40():93-8. PubMed ID: 23262354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure.
    Bentzen H; Pedersen RS; Nyvad O; Pedersen EB
    Int J Cardiol; 2004 Feb; 93(2-3):121-30. PubMed ID: 14975537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions.
    Imura H; Nakao K; Itoh H
    Front Neuroendocrinol; 1992 Jul; 13(3):217-49. PubMed ID: 1334000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
    Moltzau LR; Aronsen JM; Meier S; Skogestad J; Ørstavik Ø; Lothe GB; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    J Pharmacol Exp Ther; 2014 Sep; 350(3):681-90. PubMed ID: 25022512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-terminal fragment of C-type natriuretic peptide precursor and C-type natriuretic peptide do not correlate in patients with Chagas disease: role for neutral endopeptidase.
    Wang Y; Moreira Mda C; Heringer-Walther S; Schultheiss HP; Siems WE; Wessel N; Walther T
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):62-6. PubMed ID: 20090473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic peptides in relation to the cardiac innervation and conduction system.
    Hansson M
    Microsc Res Tech; 2002 Sep; 58(5):378-86. PubMed ID: 12226807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional sampling and the effects of experimental heart failure in sheep: differential responses in A, B and C-type natriuretic peptides.
    Charles CJ; Prickett TC; Espiner EA; Rademaker MT; Richards AM; Yandle TG
    Peptides; 2006 Jan; 27(1):62-8. PubMed ID: 16095755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of C-type natriuretic peptide expression.
    Sellitti DF; Koles N; Mendonça MC
    Peptides; 2011 Sep; 32(9):1964-71. PubMed ID: 21816187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
    Nishikimi T; Kuwahara K; Nakao K
    J Cardiol; 2011 Mar; 57(2):131-40. PubMed ID: 21296556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a natriuretic peptide family and their clinical application.
    Matsuo H
    Can J Physiol Pharmacol; 2001 Aug; 79(8):736-40. PubMed ID: 11558683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptide system in human heart failure.
    Wei CM; Heublein DM; Perrella MA; Lerman A; Rodeheffer RJ; McGregor CG; Edwards WD; Schaff HV; Burnett JC
    Circulation; 1993 Sep; 88(3):1004-9. PubMed ID: 8353861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts.
    Horio T; Tokudome T; Maki T; Yoshihara F; Suga S; Nishikimi T; Kojima M; Kawano Y; Kangawa K
    Endocrinology; 2003 Jun; 144(6):2279-84. PubMed ID: 12746286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure.
    Del Ry S; Cabiati M; Lionetti V; Simioniuc A; Caselli C; Prescimone T; Emdin M; Giannessi D
    Peptides; 2009 Sep; 30(9):1710-3. PubMed ID: 19540894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides and their therapeutic potential.
    Cho Y; Somer BG; Amatya A
    Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-type natriuretic peptide in vascular physiology and disease.
    Scotland RS; Ahluwalia A; Hobbs AJ
    Pharmacol Ther; 2005 Feb; 105(2):85-93. PubMed ID: 15670620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system.
    Chen HH; Burnett JC
    J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S22-8. PubMed ID: 9883743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.